Replication of five prostate cancer loci identified in an Asian population – Results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3)
View/ Open
Author
Lindstrom, Sara
Schumacher, Fredrick R.
Campa, Daniele
Albanes, Demetrius
Andriole, Gerald
Berndt, Sonja I.
Bueno-de-Mesquita, H. Bas
Chanock, Stephen J.
Diver, W. Ryan
Ganziano, J. Michael
Gapstur, Susan M.
Giovannucci, Edward
Haiman, Christopher A.
Henderson, Brian
Hunter, David J.
Johansson, Mattias
Kolonel, Laurence N.
Marchand, Loic Le
Ma, Jing
Stevens, Victoria L.
Trichopoulos, Dimitrios
Virtamo, Jarmo
Willett, Walter C.::94559ea206eef8a8844fc5b80654fa5b::600
Yeager, Meredith
Hsing, Ann W.
Kraft, Peter
Published Version
https://doi.org/10.1158/1055-9965.EPI-11-0870-TMetadata
Show full item recordCitation
Lindstrom, S., F. R. Schumacher, D. Campa, D. Albanes, G. Andriole, S. I. Berndt, H. B. Bueno-de-Mesquita, et al. 2011. “Replication of Five Prostate Cancer Loci Identified in an Asian Population--Results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3).” Cancer Epidemiology Biomarkers & Prevention 21 (1): 212–16. https://doi.org/10.1158/1055-9965.epi-11-0870-t.Abstract
Background: A recent genome-wide association study (GWAS) of prostate cancer in a Japanese population identified five novel regions not previously discovered in other ethnicities. In this study, we attempt to replicate these five loci in a series of nested prostate cancer case-control studies of European ancestry. Methods: We genotyped five single-nucleotide polymorphism (SNP): rs13385191 (chromosome 2p24), rs12653946 (5p15), rs1983891 (6p21), rs339331 (6p22), and rs9600079 (13q22), in 7,956 prostate cancer cases and 8,148 controls from a series of nested case-control studies within the National cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3). We tested each SNP for association with prostate cancer risk and assessed whether associations differed with respect to disease severity and age of onset. Results: Four SNPs (rs13385191, rs12653946, rs1983891, and rs339331) were significantly associated with prostate cancer risk (P values ranging from 0.01 to 1.1 x 10(-5)). Allele frequencies and ORs were overall lower in our population of European descent than in the discovery Asian population. SNP rs13385191 (C2orf43) was only associated with low-stage disease (P = 0.009, case-only test). No other SNP showed association with disease severity or age of onset. We did not replicate the 13q22 SNP, rs9600079 (P = 0.62). Conclusions: Four SNPs associated with prostate cancer risk in an Asian population are also associated with prostate cancer risk in men of European descent.Impact: This study illustrates the importance of evaluation of prostate cancer risk markers across ethnic groups. Cancer Epidemiol Biomarkers Prev; 21(1); 212-16.Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:41292547
Collections
- SPH Scholarly Articles [6362]
Contact administrator regarding this item (to report mistakes or request changes)